Quality of life, psychological adjustment, and adaptive functioning of patients with intoxication-type inborn errors of metabolism – a systematic review

Orphanet Journal of Rare Diseases

Markus A Landolt³  Matthias R Baumgartner¹  Martina Huemer²  Nina A Zeltner³ 

[1] Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland;Radiz ¿ Rare Disease Initiative Zurich, Clinical Research Priority Program for Rare Diseases, University of Zurich, Zurich, Switzerland;Department of Child and Adolescent Health Psychology, Institute of Psychology, University of Zurich, Zurich, Switzerland

关键词: Tyrosinemia;    Maple syrup urine disease;    Urea cycle disorders;    Organic acidurias;    Inherited metabolic diseases;    Inborn errors of metabolism;    Adaptive functioning;    Psychological adjustment;    Health-related quality of life;   

Others  :  1149468
DOI  :  10.1186/s13023-014-0159-8

 received in 2014-05-23, accepted in 2014-10-06,  发布年份 2014

【 摘 要 】

Background

In recent decades, considerable progress in diagnosis and treatment of patients with intoxication-type inborn errors of metabolism (IT-IEM) such as urea cycle disorders (UCD), organic acidurias (OA), maple syrup urine disease (MSUD), or tyrosinemia type 1 (TYR 1) has resulted in a growing group of long-term survivors. However, IT-IEM still require intense patient and caregiver effort in terms of strict dietetic and pharmacological treatment, and the threat of metabolic crises is always present. Furthermore, crises can affect the central nervous system (CNS), leading to cognitive, behavioural and psychiatric sequelae. Consequently, the well-being of the patients warrants consideration from both a medical and a psychosocial viewpoint by assessing health-related quality of life (HrQoL), psychological adjustment, and adaptive functioning. To date, an overview of findings on these topics for IT-IEM is lacking. We therefore aimed to systematically review the research on HrQoL, psychological adjustment, and adaptive functioning in patients with IT-IEM.

Methods

Relevant databases were searched with predefined keywords. Study selection was conducted in two steps based on predefined criteria. Two independent reviewers completed the selection and data extraction.

Results

Eleven articles met the inclusion criteria. Studies were of varying methodological quality and used different assessment measures. Findings on HrQoL were inconsistent, with some showing lower and others showing higher or equal HrQoL for IT-IEM patients compared to norms. Findings on psychological adjustment and adaptive functioning were more consistent, showing mostly either no difference or worse adjustment of IT-IEM patients compared to norms. Single medical risk factors for HrQoL, psychological adjustment, or adaptive functioning have been addressed, while psychosocial risk factors have not been addressed.

Conclusion

Data on HrQoL, psychological adjustment, and adaptive functioning for IT-IEM are sparse. Studies are inconsistent in their methodological approaches, assessment instruments and norm populations. A disease-specific standard assessment procedure for HrQoL is not available. Psychosocial risk factors for HrQoL, psychological adjustment, or adaptive functioning have not been investigated. Considering psychosocial variables and their corresponding risk factors for IT-IEM would allow evaluation of outcomes and treatments as well as the planning of effective social and psychological interventions to enhance the patients¿ HrQoL.

【 授权许可】

   
2014 Zeltner et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Brusilow S, Maestri NE: Urea cycle disorders: diagnosis, pathophysiology, and therapy. Adv Pediatr 1996, 43:127-170.
• [2]Dionisi-Vici C, Rizzo C, Burlina AB, Caruso U, Sabetta G, Uziel G, Abeni D: Inborn errors of metabolism in the Italian pediatric population: a national retrospective survey. J Pediatr 2002, 140:321-327.
• [3]De Laet C, Dionisi-Vici C, Leonard JV, McKiernan P, Mitchell G, Monti L, De Baulny HO, Pintos-Morell G, Spiekerkotter U: Recommendations for the management of tyrosinaemia type 1. Orphanet J Rare Dis 2013, 8:8. BioMed Central Full Text
• [4]Chuang DT, Shih VE: Maple syrup urine disease (branched-chain ketoaciduria). In The Metabolic and Molecular Bases of Inherited Disease. Volume II. 8th edition. Edited by Scriver CR, Beaudet AL, Sly WS, Valle D. McGraw-Hill, New York; 2001:1971-2005.
• [5]Walterfang M, Bonnot O, Mocellin R, Velakoulis D: The neuropsychiatry of inborn errors of metabolism. J Inherit Metab Dis 2013, 36:687-702.
• [6]Cohen JS, Biesecker BB: Quality of life in rare genetic conditions: a systematic review of the literature. Am J Med Genet A 2010, 152A:1136-1156.
• [7]Dey M, Landolt MA, M-K M: Health-related quality of life among children with mental disorders: a systematic review. Qual Life Res 2012, 21:1797-1814.
• [8]Fan SY, Eiser C, Ho MC: Health-related quality of life in patients with hepatocellular carcinoma: a systematic review. Clin Gastroenterol Hepatol 2010, 8:559-564. e551-510
• [9]Weber SL, Segal S, Packman W: Inborn errors of metabolism: psychosocial challenges and proposed family systems model of intervention. Mol Genet Metab 2012, 105:537-541.
• [10]Gentile JK, Ten Hoedt AE, Bosch AM: Psychosocial aspects of PKU: hidden disabilities - a review. Mol Genet Metab 2010, 99(Suppl 1):S64-67.
• [11]Varni JW, Seid M, Rode CA: The PedsQL: measurement model for the pediatric quality of life inventory. Med Care 1999, 37:126-139.
• [12]De Ridder D, Geenen R, Kuijer R, Van Middendorp H: Psychological adjustment to chronic disease. Lancet 2008, 372:246-255.
• [13]Sparrow SS, Cicchetti DV, Balla DA: Vineland Adaptive Behavior Scales, 2nd edition (Vineland-II): Survey forms manual. Pearson, Minneapolis, MN; 2005.
• [14]Mental Retardation Definition, Classification, and Systems of Supports. American Association on Mental Retardation, Washington, DC; 2002.
• [15]Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
• [16]Durlak JA: How to select, calculate, and interpret effect sizes. J Pediatr Psychol 2009, 34:917-928.
• [17]Cohen J: Statistical power analysis for the behavioural sciences. Lawrence Erlbaum Associates, Hillsdale, NJ; 1988.
• [18]Packman W, Mehta I, Rafie S, Mehta J, Naldi M, Mooney KH: Young adults with MSUD and their transition to adulthood: psychosocial issues. J Genet Couns 2012, 21:692-703.
• [19]Gramer G, Haege G, Glahn EM, Hoffmann GF, Lindner M, Burgard P: Living with an inborn error of metabolism detected by newborn screening - parents' perspectives on child development and impact on family life. J Inherit Metab Dis 2013, 37:189-195.
• [20]Mazariegos GV, Morton DH, Sindhi R, Soltys K, Nayyar N, Bond G, Shellmer D, Shneider B, Vockley J, Strauss KA: Liver transplantation for classical maple syrup urine disease: long-term follow-up in 37 patients and comparative United Network for Organ Sharing experience. J Pediatr 2012, 160:116-121 e111.
• [21]Simons A, Eyskens F, De Groof A, Van Diest E, Deboutte D, Vermeiren R: Cognitive functioning and psychiatric disorders in children with a metabolic disease. Eur Child Adolesc Psychiatry 2006, 15:207-213.
• [22]Cazzorla C, Del Rizzo M, Burgard P, Zanco C, Bordugo A, Burlina AB, Burlina AP: Application of the WHOQOL-100 for the assessment of quality of life of adult patients with inherited metabolic diseases. Mol Genet Metab 2012, 106:25-30.
• [23]Eminoglu TF, Soysal SA, Tumer L, Okur I, Hasanoglu A: Quality of life in children treated with restrictive diet for inherited metabolic disease. Pediatr Int 2013, 55:428-433.
• [24]Muelly ER, Moore GJ, Bunce SC, Mack J, Bigler DC, Morton DH, Strauss KA: Biochemical correlates of neuropsychiatric illness in maple syrup urine disease. J Clin Invest 2013, 123:1809-1820.
• [25]Beauchamp MH, Boneh A, Anderson V: Cognitive, behavioural and adaptive profiles of children with glutaric aciduria type I detected through newborn screening. J Inherit Metab Dis 2009, 32(Suppl 1):S207-213.
• [26]Grünert SC, Mullerleile S, De Silva L, Barth M, Walter M, Walter K, Meissner T, Lindner M, Ensenauer R, Santer R, Bodamer OA, Baumgartner MR, Brunner-Krainz M, Karall D, Haase C, Knerr I, Marquardt T, Hennermann JB, Steinfeld R, Beblo S, Koch HG, Konstantopoulou V, Scholl-Bürgi S, van Teeffelen-Heithoff A, Suormala T, Sperl W, Kraus JP, Superti-Furga A, Schwab KO, Sass JO: Propionic acidemia: clinical course and outcome in 55 pediatric and adolescent patients. Orphanet J Rare Dis 2013, 8:6. BioMed Central Full Text
• [27]Krivitzky L, Babikian T, Lee HS, Thomas NH, Burk-Paull KL, Batshaw ML: Intellectual, adaptive, and behavioral functioning in children with urea cycle disorders. Pediatr Res 2009, 66:96-101.
• [28]Packman W, Henderson SL, Mehta I, Ronen R, Danner D, Chesterman B, Packman S: Psychosocial issues in families affected by maple syrup urine disease. J Genet Couns 2007, 16:799-809.
• [29]Pohorecka M, Biernacka M, Jakubowska-Winecka A, Biernacki M, Kusmierska K, Kowalik A, Sykut-Cegielska J: Behavioral and intellectual functioning in patients with tyrosinemia type I. Pediatr Endocrinol Diabetes Metab 2012, 18:96-100.
• [30]Sprangers MAG, Schwartz CE: Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med 1999, 48:1507-1515.
• [31]Upton P, Lawford J, Eiser C: Parent¿child agreement across child health-related quality of life instruments: a review of the literature. Qual Life Res 2008, 17:895-913.
• [32]Eiser C, Varni JW: Health-related quality of life and symptom reporting: similarities and differences between children and their parents. Eur J Pediatr 2013, 172:1299-1304.
• [33]Hatzmann J, Valstar MJ, Bosch AM, Wijburg FA, Heymans HS, Grootenhuis MA: Predicting health-related quality of life of parents of children with inherited metabolic diseases. Acta Paediatr 2009, 98:1205-1210.
• [34]Landolt MA, Nuoffer JM, Steinmann B, Superti-Furga A: Quality of life and psychologic adjustment in children and adolescents with early treated phenylketonuria can be normal. J Pediatr 2002, 140:516-521.
• [35]Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6:e1000097.
• [36]Dulfer K, Duppen N, Van Dijk AP, Kuipers IM, Van Domburg RT, Verhulst FC, Van der Ende J, Helbing WA, Utens EM: Parental mental health moderates the efficacy of exercise training on health-related quality of life in adolescents with congenital heart disease.Pediatr Cardiol 2014, doi:10.1007/s00246-014-0961-z.
• [37]Agostini A, Moretti M, Calabrese C, Rizzello F, Gionchetti P, Ercolani M, Campieri M: Attachment and quality of life in patients with inflammatory bowel disease. Int J Colorectal Dis 2014, 29(10):1291-1296.